To preserve and improve patient visual function
HORAMA technology will help preserve or improve visual function and delay or halt disease progression in patients with rare ocular diseases, thereby limiting or preventing visual handicaps and allowing patients to maintain autonomy.
To restore patient autonomy and reduce the financial healthcare burden on society
Given the current lack of approved treatments for these rare diseases, the management of affected patients falls to society at large. The development of effective therapies would thus allow for a significant reduction in societal and healthcare costs associated with visual impairment.
In most countries, legal blindness is defined as visual acuity of less than 1/10, or defects resulting in a visual field of less than 20 degrees in the better eye with optimal visual correction. A visual loss to this extent has a significant impact on a patient’s ability to perform normal daily activities, diminishing their quality of life.